Adjuvant pembrolizumab versus observation in muscle-invasive urothelial carcinoma Journal Article

   

Authors:	Apolo, A. B.; Ballman, K. V.; Sonpavde, G.; Berg, S.; Kim, W. Y.; Parikh, R.; Teo, M. Y.; Sweis, R. F.; Geynisman, D. M.; Grivas, P.; Chatta, G.; Reichert, Z. R.; Kim, J. W.; Bilen, M. A.; McGregor, B.; Singh, P.; Tripathi, A.; Cole, S.; Simon, N.; Niglio, S.; Ley, L.; Cordes, L.; Srinivas, S.; Huang, J; Odegaard, M.; Watt, C; Petrylak, D; Hoffman‑Censits, J.; Wen, Y.; Hahn, O; Mitchell, C.; Tan, A.; Streicher, H.; Sharon, E.; Moon, H.; Woods, M.; Halabi, S.; Perez Burbano, G.; Morris, M. J.; Rosenberg, J. E.
Article Title:	Adjuvant pembrolizumab versus observation in muscle-invasive urothelial carcinoma
Journal Title:	New England Journal of Medicine
Volume:	392
Issue:	1
ISSN:	0028-4793
Publisher:	Massachusetts Medical Society
Date Published:	2025-01-02
Start Page:	45
End Page:	55
DOI:	10.1056/NEJMoa2401726
PROVIDER:	EBSCOhost
PROVIDER:	cinahl plus with full text
PMCID:	PMC11698643
PUBMED:	39282902
DOI/URL:	https://research.ebsco.com/linkprocessor/plink?id=758ff604-0834-376c-a402-d271201d9599
Notes:	The MSK Cancer Center Support Grant (P30 CA008748) is acknowledged in the PubMed record -- Source: CINAHL Plus with Full Text

https://synapse.mskcc.org/synapse/works/has_related_data_chk/222616